Skip to search boxSkip to navigationSkip to main content

Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population

*Corresponding author for this work
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 298.e11-298.e15

Journal (Volume, Issue Number)

Neurobiology of Aging (Volume 101)

Publication milestones

  • Published - 05/2021

Publication status

Published - 05/2021

ISSN

0197-4580

Publication IDs

  • Scopus: 85100257729
  • PubMed: 33541779

Abstract

Alzheimer disease (AD) is the leading cause of dementia in the elderly and occurs in all ethnic and racial groups. The apolipoprotein E (ApoE) ε4 is the most significant genetic risk factor for late-onset AD and shows the strongest effect among East Asian populations followed by non-Hispanic white populations and has a relatively lower effect in African descent populations. Admixture analysis in the African American and Puerto Rican populations showed that the variation in ε4 risk is correlated with the genetic ancestral background local to the ApoE gene. Native American populations are substantially underrepresented in AD genetic studies. The Peruvian population with up to ~80 of Amerindian (AI) ancestry provides a unique opportunity to assess the role of AI ancestry in AD. In this study, we assess the effect of the ApoE ε4 allele on AD in the Peruvian population. A total of 79 AD cases and 128 unrelated cognitive healthy controls from Peruvian population were included in the study. Genome-wide genotyping was performed using the Illumina Global screening array v2.0. Global ancestry and local ancestry analyses were assessed. The effect of the ApoE ε4 allele on AD was tested using a logistic regression model by adjusting for age, gender, and population substructure (first 3 principal components). Results showed that the genetic ancestry surrounding the ApoE gene is predominantly AI (60.6%) and the ε4 allele is significantly associated with increased risk of AD in the Peruvian population (odds ratio = 5.02, confidence interval: 2.3–12.5, p-value = 2e-4). Our results showed that the risk for AD from ApoE ε4 in Peruvians is higher than we have observed in non-Hispanic white populations. Given the high admixture of AI ancestry in the Peruvian population, it suggests that the AI genetic ancestry local to the ApoE gene is contributing to a strong risk for AD in ε4 carriers. Our data also support the findings of an interaction between the genetic risk allele ApoE ε4 and the ancestral backgrounds located around the genomic region of ApoE gene.

Funding Details

Research reported in this publication was supported in part by the Fogarty International Center of the National Institutes of Health and the National Institute of Neurological Disorders and Stroke under grant #D43TW009345 awarded to the Northern Pacific Global Health Fellows Program from National Institutes of Health, grant #D43TW009137 awarded to the Interdisciplinary Cerebrovascular Diseases Training Program in South America from National Institutes of Health, the AG054074 grant from the National Institutes on Aging, and the A2018556 F grant from the BrightFocus Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We are grateful for Erik Figueroa-Ildefonso for his contribution on the logistics and support on laboratory work.
FundersFunding numbers
NIH
-
NIA
RF1AG054074
FIC
-
NINDS
43TW009345, 43TW009137
BFF
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
54
Mentions
1
Citations
14
Social media
1